We are live on ! Find out more
KALA icon

KALA BIO

36 hedge funds and large institutions have $80.7M invested in KALA BIO in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,025% more call options, than puts

Call options by funds: $2.25M | Put options by funds: $200K

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

48% more capital inflows, than outflows

Capital inflows: $15.1M | Capital outflows: $10.1M

0% more funds holding

Funds holding: 36 → 36 (0)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

1.91% less ownership

Funds ownership: 65.24% → 63.33% (-1.9%)

Holders
36
Holders Change
–
Holders Change %
0%
% of All Funds
0.71%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
3
Increased
9
Reduced
4
Closed
2
Calls
$2.25M
Puts
$200K
Net Calls
+$2.05M
Net Calls Change
+$1.8M

KALA Hedge Fund Activity: Q4 2019 in Review

36 of the 5,095 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2019, worth a combined $80.7M — down 4.4% from $84.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new KALA positions and 2 closed out — a net gain of 1 holder — while 9 added to existing stakes and 4 trimmed.

The largest buyer was First Manhattan, opening a new position worth an estimated $1.74M. The largest seller was Wellington Management Group, exiting entirely with an estimated $5.55M sold.

  • 36 institutional investors held KALA BIO (KALA) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $80.7M of KALA BIO stock for Q4 2019, down 4.4% quarter-over-quarter.
  • 3 funds opened new KALA BIO positions in Q4 2019 and 2 closed out, a net change of +1 holder.
  • The largest KALA BIO buyer in Q4 2019 was First Manhattan, an estimated $1.74M added.
  • The largest KALA BIO seller in Q4 2019 was Wellington Management Group, an estimated $5.55M sold.

Based on aggregated 13F filings for Q4 2019.